Chemotherapy Market Overview 2024-2033 – Competitive Landscape and Strategies

Spread the love

The Chemotherapy by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Chemotherapy Market:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

According to The Business Research Company’s Chemotherapy , The chemotherapy market size has grown rapidly in recent years. It will grow from $30.89 billion in 2023 to $34.38 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to cancer incidence increase, advancements in cancer diagnosis, innovation in drug development, clinical trial activity, access to healthcare, awareness campaigns..

The chemotherapy market size is expected to see rapid growth in the next few years. It will grow to $54.86 billion in 2028 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to immunotherapy integration, biosimilar adoption, emerging markets growth, genomic profiling, supportive care advances, regulatory facilitation.. Major trends in the forecast period include digital health solutions, personalized medicine, continued oncology research, integration of artificial intelligence (ai), advancements in nanotechnology, home-based chemotherapy administration..

The increasing cancer prevalence is expected to propel the growth of the chemotherapy market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. In chemotherapy powerful chemicals are used in combination or alone for the treatment of cancer by killing fast-growing cancer cells. In addition, increasing cancer prevalence will increase the demand for chemotherapy. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1.9 million new cancer cases are expected to be diagnosed in the US, an increase from 1.8 million new cancer cases diagnosed in 2020. In the US, 609,820 cancer-related deaths are anticipated in 2023, while it was anticipated that 606,520 Americans would pass away from cancer in 2020. Therefore, the increasing cancer prevalence is driving the chemotherapy market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Major companies operating in the chemotherapy market are focused on introducing innovative solutions, such as chemotherapy infusion pumps, to gain a competitive edge in the market. Chemotherapy infusion pumps are devices that deliver chemotherapy drugs directly into the bloodstream through an IV line. These pumps are used to administer chemotherapy in a controlled manner, allowing for a slow and steady infusion of drugs into the body. For instance, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a China-based medical technology developer and manufacturer, launched AutoEx, its independently developed new chemotherapy infusion pump. In clinical practice, special infusion pumps are frequently utilized for accurate and continuous infusion to maintain the best possible blood medication concentration throughout chemotherapy, boost anti-cancer cell activity, and lessen side effects. AutoEx is designed for intravenous administration of medication for the purpose of flushing or sealing PICCs (peripherally inserted central catheters), CVCs (central venous catheters), and ports during chemotherapy. It can be used intermittently or continuously.

The chemotherapy market report table of contents includes: